# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Raymond James analyst Rahul Sarugaser downgrades Medexus Pharma (OTC:MEDXF) from Outperform to Market Perform and lowers the pr...
Upgrades
Canaccord Genuity downgrades Medexus Pharmaceuticals (OTC:MEDXF) from Speculative Buy to Hold.